Anulex is a privately-held, venture-backed orthopedic spine company founded in February 2001. Historically, surgical treatment for ailments of the spine has been focused on the boney structures of the anatomy. Anulex is one of the first companies to recognize the fundamental role of the soft tissues of the spine and their role in chronic pain. Anulex is pioneering the development of innovative technologies and techniques for the treatment of the soft tissue of the spine to reduce the persistence of pain and to reduce re-operation rates associated with a herniated or damaged intervertebral disc. Anulex’s commercially available annular repair products, the Xclose Soft Tissue Repair System and the Inclose Surgical Mesh System, are intended to improve patient outcomes by repairing the annulus after discectomy.